Evidence map›Paper›PMID 34103251›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2021

Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.

Deirdre Gilpin, Lucas R Hoffman, Agathe Ceppe, Marianne S Muhlebach

Open access · greenAbstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Microbiology spectrum · 2024
    Article
  4. Article
  5. Article
  6. Analysis ofbioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Biofilm Formation byInternational journal of molecular sciences · 2022
    Review
  9. Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  10. Biofilm Formation in Methicillin-ResistantFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Deirdre GilpinDepartment of Pharmacy Services, Queens University, Belfast, UK. Electronic address: d.f.gilpin@qub.ac.uk.
Lucas R HoffmanDepartment of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA, USA. Electronic address: lhoffm@uw.edu.
Agathe CeppeMarisco Lung Institute, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ceppe@email.unc.edu.
Marianne S MuhlebachMarisco Lung Institute, University of North Carolina, Chapel Hill, NC, USA; Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: marianne_muhlebach@med.unc.edu.
Queens University · BDSeattle Children's Hospital · USUniversity of North Carolina at Chapel Hill · USUniversity of North Carolina System · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI PRADEEP k SINGH · 2010 to 2026
$21.4M
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric diseaseK24HL141669 · NHLBI · UNIVERSITY OF WASHINGTON · PI Lucas R Hoffman · 2018 to 2026
$929k
NCATS NIH HHS UL1 TR002489NHLBI NIH HHS K24 HL141669NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

backgroundChronic methicillin resistant Staphylococcus aureus (MRSA) in CF is associated with worse outcomes compared to early or intermittent infection. This observation could be related to adaptive bacterial changes such as biofilm formation or anaerobic growth.

methodsMRSA isolates stored from incident and during chronic (>2 years) infection were included at two study sites. MRSA isolates were characterised by spa-typing, antimicrobial susceptibility testing, biofilm formation and haemolysis under aerobic and anaerobic culture conditions.

resultsPaired MRSA isolates from 49 patients were included. Mean age at incident infection was 9.7±1.2 years with mild to moderate lung disease (FEV

conclusionsPersistent MRSA infection is frequently associated with clinical decline. Anaerobic growth conditions, which occur in CF airways, affect the expression of virulence factors and antibiotic susceptibility of MRSA more than duration of infection.

Indexed as

AdolescentChildCystic FibrosisHumansMethicillin-Resistant Staphylococcus aureusPhenotypeAdaptationAnaerobeAntimicrobial resistanceHaemolysisOutcomeStaphylococcus aureus

Identifiers

PMID34103251
PMCPMC8734588
OpenAlexW3167737269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.